ClinicalTrials.gg
Status unknownNCT06603207RAPD-MRUpdated Sep 20, 2024

Study of the Causal Link Between Rheumatoid Arthritis and Periodontitis Using Mendelian Randomization

An observational study in Rheumatoid Arthritis and Periodontitis, sponsored by Zhibin Xu. Status unknown. Per ClinicalTrials.gov, last updated 2024-09-20.

Sponsored by Zhibin Xu · Observational

The sponsor has not verified this record recently (last verified Sep 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
220,000
Sex
All
01

Study summary

This study aims to investigate the causal relationship between rheumatoid arthritis and periodontitis using Mendelian randomization. Data will be sourced from genome-wide association studies (GWAS) to explore genetic associations and assess potential risk factors in an East Asian population.

Read the detailed description

The purpose of this study is to explore the causal association between rheumatoid arthritis (RA) and periodontitis using Mendelian randomization (MR). RA and periodontitis share similar inflammatory pathways and immune responses, but their causal relationship remains unclear. This study will utilize genome-wide association studies (GWAS) data from an East Asian population to identify single nucleotide polymorphisms (SNPs) associated with RA and assess their potential impact on the risk of developing periodontitis. Statistical methods such as inverse-variance weighting, MR-Egger regression, and weighted median analysis will be employed to analyze the data. The findings may provide insights into the shared genetic basis and causal relationships between these two conditions, offering potential targets for preventive strategies.

02

Conditions studied

  • Rheumatoid Arthritis
  • Periodontitis

Keywords

  • Mendelian Randomization
  • Genome-Wide Association Study (GWAS)
  • Inflammatory Diseases
  • Genetic Risk Factors
  • SNP (Single Nucleotide Polymorphism)
03

In context

Arthritis, Rheumatoid

2,962 studies on the registry are indexed under Arthritis, Rheumatoid; 396 are open to participants now.

This study's planned enrollment of 220,000 is above the median of 176 across 854 observational studies indexed under Arthritis, Rheumatoid.

Browse Arthritis, Rheumatoid studies →

Lead sponsor

Zhibin Xu is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study utilizes genetic data from an East Asian population, sourced from publicly available genome-wide association studies (GWAS) focused on rheumatoid arthritis and periodontitis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants included in the genome-wide association study (GWAS) database.
  • Subjects with available genotypic data relevant to rheumatoid arthritis and periodontitis.

Exclusion criteria

Exclusion Criteria:

  • Individuals without complete genotypic data or those with missing critical phenotypic information.
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
220,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Causal Association Between Rheumatoid Arthritis and Periodontitis

    This study uses Mendelian randomization to evaluate the causal relationship between rheumatoid arthritis (RA) and periodontitis in the East Asian population. The analysis utilizes genome-wide association study (GWAS) data, employing inverse variance weighting (IVW), weighted median, and MR-Egger regression methods to assess the genetic relationship and the risk contribution of RA to the development of periodontitis.

    Time frame: Data collected from 2023 to 2024.

Secondary outcomes

  1. Analysis of Genetic Pleiotropy and Confounders

    Evaluation of the presence of genetic pleiotropy and its potential effect on the association between rheumatoid arthritis and periodontitis.

    Time frame: 2023 to 2024

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Li X, Ouyang Y, Liang L, Li Y. Causal association between rheumatoid arthritis and periodontitis: A Mendelian randomization study. Medicine (Baltimore). 2026 Jun 5;105(23):e49095. doi: 10.1097/MD.0000000000049095. PubMed 42260828 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2024; primary completion for Nov 2024, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2024
First posted
Sep 19, 2024
StartEst.
Oct 1, 2024
Primary completionEst.
Nov 1, 2024
CompletionEst.
Dec 1, 2024
Last update
Sep 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06603207
Lead sponsor
Zhibin Xu
Collaborators
Zhongshan People's Hospital, Guangdong, China
Responsible party
Zhibin Xu (Guangzhou Institute of Respiratory Disease, Guangzhou Institute of Respiratory Disease) — Sponsor-investigator
First posted
Sep 19, 2024
Start date
Oct 1, 2024 (estimated)
Primary completion
Nov 1, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Sep 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion